Thirty Years of Medical Surveillance in Perfluooctanoic Acid Production Workers

  title={Thirty Years of Medical Surveillance in Perfluooctanoic Acid Production Workers},
  author={Giovanni Costa and Samantha Sartori and Dario Consonni},
  journal={Journal of Occupational and Environmental Medicine},
Objective: To report health outcomes of 30 years (1978–2007) of medical surveillance of workers engaged in a perfluooctanoic acid (PFOA) production plant. Methods: Fifty-three males workers (20 to 63 years) were submitted every year to medical examination and blood chemical chemistry tests, and serum PFOA dosage. Results: In the latest survey PFOA serum levels ranged from 0.20 to 47.04 μg/mL in currently exposed workers, and from 0.53 to 18.66 μg/mL in those formerly exposed. No clinical… 

Positive associations of serum Perfluoroalkyl substances with uric acid and hyperuricemia in children from Taiwan

PFOA was found to be associated with 44 elevated serum levels of uric acid in Taiwanese children, especially boys, and further research is needed to elucidate these links.

Association of perfluorooctanoic acid and perfluorooctane sulfonate with serum lipids among adults living near a chemical plant.

Perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS) are compounds that do not occur in nature but have been widely used since World War II and persist indefinitely in the environment.

Per- and polyfluoroalkyl substances in human serum and urine samples from a residentially exposed community.

Per- and polyfluoroalkyl substances and male reproductive health: a systematic review of the epidemiological evidence

Assessment of available evidence on associations between PFAS exposures in different stages of life and semen quality, reproductive hormones, cryptorchidism, hypospadias, and testicular cancer concluded that a lack of consistency across studies limited conclusions of overall evidence.

Perfluorooctanoic acid exposure is associated with elevated homocysteine and hypertension in US adults

Background exposure to PFOA may continue a risk factor for the development of cardiovascular diseases, as measured by homocysteine level and blood pressure in a representative sample of US adults.

Association of polyfluoroalkyl chemical exposure with serum lipids in children.

Positive association between perfluoroalkyl chemicals and hyperuricemia in children.

It is found that serum levels of PFOA and PFOS were positively associated with hyperuricemia, independent of age, sex, race/ethnicity, body mass index, annual household income, physical activity, serum total cholesterol, and serum cotinine levels.

Modeled Perfluorooctanoic Acid (PFOA) Exposure and Liver Function in a Mid-Ohio Valley Community

Modeled perfluorooctanoic acid exposure and liver function in a Mid-Ohio Valley community is consistent with previous cross-sectional studies showing association between PFOA and ALT, a marker of hepatocellular damage.



Mortality among employees of a perfluorooctanoic acid production plant.

  • F. GillilandJ. Mandel
  • Medicine, Biology
    Journal of occupational medicine. : official publication of the Industrial Medical Association
  • 1993
PFOA may increase prostate cancer mortality by altering reproductive hormones in male workers because of its reported role in rodent hepatocarcinogenesis and human health effects associated with PFOA exposure.

Assessment of lipid, hepatic, and thyroid parameters with serum perfluorooctanoate (PFOA) concentrations in fluorochemical production workers

  • G. OlsenL. R. Zobel
  • Medicine
    International archives of occupational and environmental health
  • 2007
There was no evidence that employees’ serum PFOA concentrations were associated with total cholesterol or LDL, and several explanations are offered for the inconsistent triglyceride associations with PFO a including both methodological as well as biological possibilities.

An epidemiologic investigation of reproductive hormones in men with occupational exposure to perfluorooctanoic acid.

Results provide reasonable assurance that, in this production setting, there were no significant hormonal changes associated with PFOA at the serum levels measured, compared with those levels reported to cause effects in laboratory animal studies.

Longitudinal Study of Serum Lipids and Liver Enzymes in Workers With Occupational Exposure to Ammonium Perfluorooctanoate

These medical surveillance data collected on workers for up to 25 years contributes useful information on the effects of ammonium perfluorooctanoate exposure on human liver and lipid chemistry.

Toxicity and toxicokinetics of perfluorooctanoic acid in humans and animals.

It is increasingly suspect that PFOA accumulates and affects human health, although the toxicokinetics of PFOB in humans remain unclear.

Serum concentrations of 11 polyfluoroalkyl compounds in the u.s. population: data from the national health and nutrition examination survey (NHANES).

The concentrations of most PFCs were similar regardless of the participants' ages but were higher in males than in females, and higher education was associated with higher concentrations of PFOS and PFOA.

Serum concentrations of polyfluoroalkyl compounds in Faroese whale meat consumers.

The high frequency of detection of most PFCs suggests widespread exposure in the Faroe Islands already by the early 1990s, with whale meat being an important source.

Half-Life of Serum Elimination of Perfluorooctanesulfonate,Perfluorohexanesulfonate, and Perfluorooctanoate in Retired Fluorochemical Production Workers

Humans appear to have a long half-life of serum elimination of PFOS, PFHS, and PFOA, which may be due, in part, to a saturable renal resorption process.

Epidemiologic Assessment of Worker Serum Perfluorooctanesulfonate (PFOS) and Perfluorooctanoate (PFOA) Concentrations and Medical Surveillance Examinations

Serum concentrations of PFOS and perfluorooctanoate (PFOA, C7F15CO2−, used as a fluoropolymer emulsifier) were measured via mass spectrometry methods and there were no substantial changes in hematological, lipid, hepatic, thyroid, or urinary parameters consistent with the known toxicological effects ofPFOS or PFOA in cross-sectional or longitudinal analyses of the workers’ measured serum fluorochemical concentrations.